Piscataqua Savings Bank’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-75
Closed -$990 351
2024
Q2
$990 Hold
75
﹤0.01% 339
2024
Q1
$3.45K Hold
75
﹤0.01% 327
2023
Q4
$5.07K Hold
75
﹤0.01% 290
2023
Q3
$5.4K Hold
75
﹤0.01% 295
2023
Q2
$5.55K Buy
75
+50
+200% +$2.96K ﹤0.01% 294
2023
Q1
$1.32K Hold
25
﹤0.01% 340
2022
Q4
$1.69K Hold
25
﹤0.01% 322
2022
Q3
$3K Hold
25
﹤0.01% 299
2022
Q2
$2K Hold
25
﹤0.01% 309
2022
Q1
$4K Buy
+25
New +$4.87K ﹤0.01% 310
2021
Q4
Sell
-13
Closed -$6K 343
2021
Q3
$6K Buy
+13
New +$6.33K 0.01% 288

Other funds holding DNA

Piscataqua Savings Bank's DNA Position: Q3 2024 in Review

Piscataqua Savings Bank sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 75 shares — an estimated $990 sold.

Piscataqua Savings Bank first reported a position in DNA in Q3 2021 and held it in 11 quarters. The position peaked at $6K in Q3 2021. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Piscataqua Savings Bank reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Piscataqua Savings Bank sold 75 Ginkgo Bioworks shares in Q3 2024, an estimated $990.
  • Piscataqua Savings Bank first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 11 quarters.
  • Piscataqua Savings Bank's Ginkgo Bioworks position peaked at $6K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Piscataqua Savings Bank's 13F filing for Q3 2024, filed 15 Oct 2024.